Click here for prescribing information
Adverse Event Reporting details can be found at the bottom of this page
The following web page is intended for UK healthcare professionals only. Waylivra is authorised for human use in the UK and Republic of Ireland but is only marketed and available within the UK.
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Swedish Orphan Biovitrum Ltd at [email protected] or Telephone +44 (0) 800 111 4754
PP-29282